IFLScience on MSN14h
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Medical Xpress on MSN15d
Early immune system changes contribute to lung damage in cystic fibrosisDespite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
The images generated are also used as the basis for computer models of lung microstructure and physiology ... and to evaluate new treatments by Pharma in the UK and EU. Cystic Fibrosis (CF) is a ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Cystic fibrosis (CF) is a progressive genetic disease that adversely affects a person's lungs, pancreas and other vital organs, says Dr. Michael Boyle, president and CEO of the Cystic Fibrosis ...
Image: Adobe Stock “Improvements in ... reports of pyrexia (21%), headache (18%), infective pulmonary exacerbation of cystic fibrosis (17%) and oropharyngeal pain (17%). Among those who reported ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback